← FDA Drug Approvals (Drugs@FDA)

YUPELRI

NDA · New Drug Application · Sponsor: MYLAN IRELAND LTD · Approved 2018-11-09

Drug application

FDA Application #

NDA210598

Application type

New Drug Application

Brand name

YUPELRI

Generic name

REVEFENACIN

Active ingredients

REVEFENACIN

Dosage form

SOLUTION

Route

INHALATION

Marketing status

Prescription

Sponsor

MYLAN IRELAND LTD

Manufacturer

Viatris Specialty LLC

First approval

2018-11-09

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown